Structural Aspect of Hydroxyethyl-Starch-Anticancer-Drug-Conjugates as State-of-the-Art Drug Carriers
Cancer is a genetic disorder and its treatment usually requires a long time and expensive diagnosis. While chemotherapy is the most conventional approach in treating most cancers, patients often suffer from undesired side effects due to various pharmacokinetic aspects. To address this issue, target-...
Saved in:
Main Authors: | Koushik Chandra (Author), Sansa Dutta (Author), Haradhan Kolya (Author), Chun-Won Kang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydroxyethyl starch related pruritus: Neurophysiological exploration
by: Emilie Brenaut, et al.
Published: (2014) -
Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency
by: Christian J. Wiedermann, et al.
Published: (2017) -
Hydroxyethyl starch conjugates co-assembled nanoparticles promote photodynamic therapy and antitumor immunity by inhibiting antioxidant systems
by: Xiang Chen, et al.
Published: (2024) -
Effect of hydroxyethyl starch on acidosis in patients with aluminum phosphide poisoning
by: Gholamabbas Kafi, et al.
Published: (2019) -
Oxidation- and Temperature-Responsive Poly(hydroxyethyl acrylate-<i>co</i>-phenyl vinyl sulfide) Micelle as a Potential Anticancer Drug Carrier
by: Tae Hoon Kim, et al.
Published: (2019)